马普替林与帕罗西汀治疗产后抑郁的临床研究  

Clinical Study on the Treatment of Postpartum Depression by Maprotiline and Paroxetine

作　　者：郑兆秋 

机构地区：[1]吉林省梅河口市第二医院妇产科,135022

出　　处：《中国卫生标准管理》2015年第30期113-114,共2页China Health Standard Management

摘　　要：目的研究马普替林与帕罗西汀治疗产后抑郁的临床效果。方法搜集2014年9月-2015年9月在我院接受治疗的产后抑郁患者66例，分为两组，观察并比较两组患者的治疗效果。结果实验组和对照组患者的治疗总有效率分别为96．97％、93．93％，两组相比差异无统计学意义（P〉0．05），实验组患者不良反应发生率为6．06％，与对照组15．15％相比，差异有统计学意义（P〈0．05）。结论马普替林与帕罗西汀在治疗产后抑郁方面疗效相当，但帕罗西汀的起效更快，不良反应更小。Objective To study the clinical effect of the treatment of postpartum depression by maprotiline and paroxetine. Methods 66 cases of postpartum depression treated in our hospital from September 2014 to September 2015 were divided into two groups, and the treatment effect of the two groups were observed and compared. Results The total effective rate of the experimental group and the control group were 96.97%, 93.93%, two groups compared with no significant difference （P〉0.05 ） . The incidence of adverse reactions in the experimental group was 15.15%, compared with the control group, there were significant differences （P 〈 0.05 ） . Conclusion The efficacy of maprotiline and paroxetine in the treatment of postpartum depression is similar, but paroxetine＇s effect is faster, less adverse reactions.

关 键 词：马普替林 帕罗西汀 产后抑郁 

分 类 号：R711[医药卫生—妇产科学]